James E Flynn
10% Owner, Other; Director, 10% Owner, Other · 4 filings · Latest: Jun 16, 2026
Larimar Therapeutics, Inc.
Nuvalent, Inc.
Parabilis Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LRMR | James E Flynn | Director, 10% Owner, Other | Feb 27, 2026 | Purchase | $5.00 | 5,000,000 | $25.0M | 6,207,982 |